Wells Fargo’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.38M | Sell |
42,279
-48,839
| -54% | -$3.18M | ﹤0.01% | 3134 |
|
|
2025
Q4 | $7.3M | Buy |
91,118
+39,270
| +76% | +$2.64M | ﹤0.01% | 2323 |
|
|
2025
Q3 | $2.53M | Buy |
51,848
+4,775
| +10% | +$296K | ﹤0.01% | 3154 |
|
|
2025
Q2 | $3.51M | Buy |
47,073
+18,868
| +67% | +$1.25M | ﹤0.01% | 2739 |
|
|
2025
Q1 | $1.79M | Sell |
28,205
-9,678
| -26% | -$658K | ﹤0.01% | 3247 |
|
|
2024
Q4 | $2.96M | Sell |
37,883
-17,161
| -31% | -$1.38M | ﹤0.01% | 2874 |
|
|
2024
Q3 | $4.42M | Sell |
55,044
-2,214
| -4% | -$179K | ﹤0.01% | 2436 |
|
|
2024
Q2 | $4.74M | Buy |
57,258
+25,129
| +78% | +$2.21M | ﹤0.01% | 2294 |
|
|
2024
Q1 | $2.74M | Buy |
32,129
+240
| +0.8% | +$18.8K | ﹤0.01% | 2729 |
|
|
2023
Q4 | $2.73M | Buy |
31,889
+957
| +3% | +$82.7K | ﹤0.01% | 2658 |
|
|
2023
Q3 | $2.77M | Sell |
30,932
-9,875
| -24% | -$882K | ﹤0.01% | 2546 |
|
|
2023
Q2 | $3.47M | Buy |
40,807
+13,507
| +49% | +$1.14M | ﹤0.01% | 2444 |
|
|
2023
Q1 | $2.26M | Buy |
27,300
+13,255
| +94% | +$1.07M | ﹤0.01% | 2763 |
|
|
2022
Q4 | $1.1M | Sell |
14,045
-1,838
| -12% | -$148K | ﹤0.01% | 3188 |
|
|
2022
Q3 | $1.18M | Buy |
15,883
+2,663
| +20% | +$191K | ﹤0.01% | 3129 |
|
|
2022
Q2 | $862K | Sell |
13,220
-49,887
| -79% | -$2.95M | ﹤0.01% | 3384 |
|
|
2022
Q1 | $3.99M | Sell |
63,107
-2,723
| -4% | -$148K | ﹤0.01% | 2650 |
|
|
2021
Q4 | $3.49M | Sell |
65,830
-309,991
| -82% | -$18.9M | ﹤0.01% | 2928 |
|
|
2021
Q3 | $26.5M | Sell |
375,821
-126,508
| -25% | -$7.98M | 0.01% | 1444 |
|
|
2021
Q2 | $33.5M | Sell |
502,329
-48,243
| -9% | -$3.41M | 0.01% | 1325 |
|
|
2021
Q1 | $61.1M | Sell |
550,572
-665,468
| -55% | -$82.3M | 0.01% | 942 |
|
|
2020
Q4 | $144M | Buy |
1,216,040
+180,109
| +17% | +$19.4M | 0.03% | 488 |
|
|
2020
Q3 | $90.4M | Buy |
1,035,931
+171,266
| +20% | +$15M | 0.03% | 606 |
|
|
2020
Q2 | $77.4M | Buy |
864,665
+86,522
| +11% | +$8.74M | 0.02% | 654 |
|
|
2020
Q1 | $77.5M | Buy |
778,143
+69,730
| +10% | +$7.56M | 0.03% | 560 |
|
|
2019
Q4 | $81.4M | Sell |
708,413
-210,126
| -23% | -$25.4M | 0.02% | 688 |
|
|
2019
Q3 | $116M | Sell |
918,539
-206,728
| -18% | -$26.2M | 0.03% | 511 |
|
|
2019
Q2 | $135M | Buy |
1,125,267
+165,586
| +17% | +$16.3M | 0.04% | 454 |
|
|
2019
Q1 | $84M | Buy |
959,681
+62,238
| +7% | +$5.66M | 0.03% | 626 |
|
|
2018
Q4 | $89.8M | Buy |
897,443
+53,412
| +6% | +$5.61M | 0.03% | 552 |
|
|
2018
Q3 | $96.7M | Sell |
844,031
-239,928
| -22% | -$24.8M | 0.03% | 603 |
|
|
2018
Q2 | $97.2M | Sell |
1,083,959
-831,329
| -43% | -$70.2M | 0.03% | 586 |
|
|
2018
Q1 | $140M | Sell |
1,915,288
-202,417
| -10% | -$13.9M | 0.04% | 448 |
|
|
2017
Q4 | $123M | Sell |
2,117,705
-641,752
| -23% | -$33.8M | 0.04% | 485 |
|
|
2017
Q3 | $124M | Sell |
2,759,457
-28,665
| -1% | -$1.19M | 0.04% | 467 |
|
|
2017
Q2 | $110M | Buy |
2,788,122
+238,294
| +9% | +$9.79M | 0.04% | 512 |
|
|
2017
Q1 | $103M | Buy |
2,549,828
+217,836
| +9% | +$8.51M | 0.03% | 517 |
|
|
2016
Q4 | $93.7M | Sell |
2,331,992
-17,641
| -0.8% | -$665K | 0.03% | 540 |
|
|
2016
Q3 | $85.1M | Sell |
2,349,633
-317,751
| -12% | -$10.9M | 0.03% | 563 |
|
|
2016
Q2 | $77.3M | Buy |
2,667,384
+620,571
| +30% | +$18.8M | 0.03% | 568 |
|
|
2016
Q1 | $71.6M | Sell |
2,046,813
-238,146
| -10% | -$7.69M | 0.03% | 588 |
|
|
2015
Q4 | $73.7M | Sell |
2,284,959
-151,425
| -6% | -$4.91M | 0.03% | 581 |
|
|
2015
Q3 | $78.7M | Buy |
2,436,384
+83,889
| +4% | +$3.16M | 0.03% | 550 |
|
|
2015
Q2 | $97.3M | Buy |
2,352,495
+1,181,502
| +101% | +$49.8M | 0.04% | 505 |
|
|
2015
Q1 | $52.6M | Buy |
1,170,993
+59,955
| +5% | +$2.51M | 0.02% | 770 |
|
|
2014
Q4 | $41.6M | Buy |
1,111,038
+407,837
| +58% | +$14.9M | 0.02% | 852 |
|
|
2014
Q3 | $24.6M | Buy |
703,201
+68,056
| +11% | +$2.43M | 0.01% | 1133 |
|
|
2014
Q2 | $22.4M | Sell |
635,145
-185
| -0% | -$6.18K | 0.01% | 1207 |
|
|
2014
Q1 | $20.7M | Sell |
635,330
-292,256
| -32% | -$11.2M | 0.01% | 1239 |
|
|
2013
Q4 | $39.1M | Sell |
927,586
-36,465
| -4% | -$1.5M | 0.02% | 872 |
|
|
2013
Q3 | $38.4M | Buy |
964,051
+49,017
| +5% | +$2.06M | 0.02% | 826 |
|
|
2013
Q2 | $37.8M | Buy |
+915,034
| New | +$37M | 0.02% | 771 |
|
Other funds holding HAE
VPM
VCM
RRAM
Wells Fargo's HAE Position: Q1 2026 in Review
Wells Fargo reduced its Haemonetics (HAE) stake by 54% in Q1 2026, selling an estimated $3.18M and leaving 42,279 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #3134.
Wells Fargo first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $144M in Q4 2020. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Wells Fargo held 42,279 shares of Haemonetics worth $2.38M as of Q1 2026.
- Wells Fargo sold 48,839 Haemonetics shares in Q1 2026, an estimated $3.18M.
- Haemonetics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3134 holding.
- Wells Fargo first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Haemonetics position peaked at $144M in Q4 2020.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.